Dr Reddys Laboratories (RDY) Income from Continuing Operations (2012 - 2026)

Dr Reddys Laboratories' Income from Continuing Operations history runs 15 years deep, the most recent figure standing at 24120848.21 for Q1 2026.

• In Q1 2026, Income from Continuing Operations fell 86.84% year-over-year to 24120848.21; the TTM figure through Mar 2026 stood at 483865882.4 (down 27.03% YoY), while the FY2026 annual figure was 452000000.0, down 32.64% from the prior year.
• Income from Continuing Operations was 24120848.21 for Q1 2026 at Dr Reddys Laboratories, down from 133585807.3 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 202835143.39 in Q4 2023 to a low of 152.0 in Q3 2022.
• Historically, Income from Continuing Operations has averaged 139127621.55 across 5 years, with a median of 145327566.3 in 2022.
• The sharpest annual moves came in 2022 and 2023: Income from Continuing Operations sank 100.0% in 2022, then surged 117786349.35% in 2023.
• A 5-year view of Income from Continuing Operations shows it stood at 116829853.75 in 2022, then soared by 73.62% to 202835143.39 in 2023, then decreased by 18.03% to 166261738.78 in 2024, then declined by 19.65% to 133585807.3 in 2025, then tumbled by 81.94% to 24120848.21 in 2026.
• The last three Income from Continuing Operations figures came in at 24120848.21 (Q1 2026), 133585807.3 (Q4 2025), and 142857281.72 (Q2 2025), per Business Quant data.